Named on one round in the feed.
Since 2025-12-15
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Link Cell Therapies An oncology cell therapy company utilizing its proprietary logic-gating technology to develop next-generation CAR-T therapeutics for solid tumors and hematologic malignancies | Series A Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $60M | 2025-12-15 | [ LEAD ] |